Evidence map›Paper›PMID 26070664›Full record

ArticleMolecular & cellular proteomics : MCP2015

The Epoxyeicosatrienoic Acid Pathway Enhances Hepatic Insulin Signaling and is Repressed in Insulin-Resistant Mouse Liver.

Alexander Schäfer, Susanne Neschen, Melanie Kahle, Hakan Sarioglu, Tobias Gaisbauer, Axel Imhof, Jerzy Adamski, Stefanie M Hauck, Marius Ueffing

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Intestinal CD4Molecular medicine reports · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epoxyeicosatrienoic acids and glucose homeostasis in mice and men.Prostaglandins & other lipid mediators · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Alexander SchäferFrom the ‡Research Unit Protein Science, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg; §German Center for Diabetes Research (DZD), Neuherberg, Germany;
Susanne Neschen§German Center for Diabetes Research (DZD), Neuherberg, Germany; ¶Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg;
Melanie Kahle§German Center for Diabetes Research (DZD), Neuherberg, Germany; ¶Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg;
Hakan SariogluFrom the ‡Research Unit Protein Science, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg; §German Center for Diabetes Research (DZD), Neuherberg, Germany;
Tobias Gaisbauer§German Center for Diabetes Research (DZD), Neuherberg, Germany; ¶Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg;
Axel Imhof‖Munich Center of Integrated Protein Science, Adolf-Butenandt Institute, Ludwig Maximilians University of Munich, Germany, Schillerstraβe 44, 80336 Munich;
Jerzy Adamski§German Center for Diabetes Research (DZD), Neuherberg, Germany; ¶Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg; **Institute of Experimental Genetics, Technical University Munich, Freising-Weihenstephan, Germany;
Stefanie M HauckFrom the ‡Research Unit Protein Science, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg; §German Center for Diabetes Research (DZD), Neuherberg, Germany; hauck@helmholtz-muenchen.de.
Marius UeffingFrom the ‡Research Unit Protein Science, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Germany, Ingolstädter Landstr.1 8674 Neuherberg; §German Center for Diabetes Research (DZD), Neuherberg, Germany; ‡‡Centre of Ophthalmology, Institute for Ophthalmic Research, University of Tübingen, Germany, Röntgenweg 11,72076 Tübingen.
Deutsches Diabetes-Zentrum e.V. · DEGerman Center for Diabetes Research · DEHelmholtz Zentrum München · DELudwig-Maximilians-Universität München · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although it is widely accepted that ectopic lipid accumulation in the liver is associated with hepatic insulin resistance, the underlying molecular mechanisms have not been well characterized.Here we employed time resolved quantitative proteomic profiling of mice fed a high fat diet to determine which pathways were affected during the transition of the liver to an insulin-resistant state. We identified several metabolic pathways underlying altered protein expression. In order to test the functional impact of a critical subset of these alterations, we focused on the epoxyeicosatrienoic acid (EET) eicosanoid pathway, whose deregulation coincided with the onset of hepatic insulin resistance. These results suggested that EETs may be positive modulators of hepatic insulin signaling. Analyzing EET activity in primary hepatocytes, we found that EETs enhance insulin signaling on the level of Akt. In contrast, EETs did not influence insulin receptor or insulin receptor substrate-1 phosphorylation. This effect was mediated through the eicosanoids, as overexpression of the deregulated enzymes in absence of arachidonic acid had no impact on insulin signaling. The stimulation of insulin signaling by EETs and depression of the pathway in insulin resistant liver suggest a likely role in hepatic insulin resistance. Our findings support therapeutic potential for inhibiting EET degradation.

Indexed as

AnimalsCell LineDiet, High-FatEicosanoidsHepatocytesInsulinInsulin ResistanceLiverMaleMiceMice, Inbred C3HProteomicsSafflower OilSignal TransductionEicosanoidsInsulinSafflower Oil

Identifiers

PMID26070664
PMCPMC4597150
OpenAlexW2142200881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.